| Company | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| BIOCRYST PHARMACEUTICALS INC | Director | Common Stock | 68,863 | $416,621 | $6.05 | 13 Jun 2023 | Direct |
| EYENOVIA, INC. | Director | Stock Option (right to buy) | 30,769 | $184,922 | $6.01 | 16 Jun 2022 | Direct |
| EYENOVIA, INC. | Director | Common Stock, par value $.0001 | 64,544 | $87,780 | $1.36 | 16 Jun 2022 | Direct |
| BIOCRYST PHARMACEUTICALS INC | Director | Automatic Stock Option Grant | 39,072 | 13 Jun 2023 | Direct |
| Symbol | Company | Period | Transactions | Value $ | Form Type | Role | Filing Time |
|---|---|---|---|---|---|---|---|
| BCRX | BIOCRYST PHARMACEUTICALS INC | 13 Jun 2023 | 2 | $0 | 4 | Director | 15 Jun 2023, 16:42 |
| BCRX | BIOCRYST PHARMACEUTICALS INC | 31 Jan 2023 | 2 | +$25,650 | 4 | Director | 02 Feb 2023, 16:15 |
| EYEN | EYENOVIA, INC. | 16 Jun 2022 | 2 | $0 | 4 | Director | 21 Jun 2022, 14:19 |
| BCRX | BIOCRYST PHARMACEUTICALS INC | 07 Jun 2022 | 2 | $0 | 4 | Director | 09 Jun 2022, 16:40 |
| EYEN | EYENOVIA, INC. | 19 May 2022 | 1 | +$22,000 | 4 | Director | 23 May 2022, 08:49 |
| EYEN | EYENOVIA, INC. | 17 Nov 2021 | 2 | $0 | 4 | Director | 22 Nov 2021, 08:09 |
| BCRX | BIOCRYST PHARMACEUTICALS INC | 13 Sep 2021 | 3 | -$43,800 | 4 | Director | 15 Sep 2021, 16:26 |
| EYEN | EYENOVIA, INC. | 11 Jun 2021 | 3 | +$32,512 | 4 | Director | 15 Jun 2021, 16:26 |
| BCRX | BIOCRYST PHARMACEUTICALS INC | 25 May 2021 | 1 | $0 | 4 | Director | 27 May 2021, 16:33 |